OVERVIEW

Advances in Assessing & Treating Severe Hypoglycemia In Practice: Severe Hypoglycemia is Still a Serious & Significant Problem in Both Type 1 & Type 2 Diabetes is organized by Taking Control of Your Diabetes (TCOYD).

Description:
Severe Hypoglycemia is still a serious and significant problem in persons with type 1 and type 2 diabetes treated with sulfonylureas and/or insulin. Providers can help to identify, prevent and address this problem by assessing patients at risk. Avoidance is the first step and being prepared with the best rescue therapies is essential for rapid recovery. We’re taking a deep dive into what you need to know to address hypos in your patients with diabetes.

Learning Objectives:
After Completing this Activity, Participants Should be Able to:
1.  Describe the clinical, emotional and public health significance of Severe Hypoglycemia in persons with T1D and T2D treated with sulfonylureas and or insulin.
2.  Assess patients at risk for Severe Hypoglycemia and discuss recognition and treatment strategies that address individual treatment barriers.
3.  Implement a care and education plan for providers to educate their patients about Severe Hypoglycemia using a glucagon option appropriate for them and to ensure each patient has an unexpired glucagon kit at home.

Credits
  • 1 AMA PRA Category 1 Credit™
  • 1 Contact Hours
  • 1 CPEUs
  • TARGET AUDIENCE

    NursingPharmacistPhysician AssistantHealthcare ProvidersEndocrinologistsPrimary Care PhysicianDiabetologistsNurseHealthcare ProfessionalsNursesHealth care and nurse practitioners

    SPECIALITIES

    EndocrinologyEndocrinology, Metabolism and Diabetes

    TERMS & CONDITIONS

    Disclaimer:
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

    RELATED ONLINE COURSES